Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma
BackgroundsThe pandemic of overweight and obesity (quantified by body mass index (BMI) ≥ 25) has rapidly raised the patient number of non-alcoholic fatty hepatocellular carcinoma (HCC), and several clinical trials have shown that BMI is associated with the prognosis of HCC. However, whether overweig...
Main Authors: | Ning-Ning Feng, Xi-Yue Du, Yue-Shan Zhang, Zhi-Kai Jiao, Xiao-Hui Wu, Bao-Ming Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.1061091/full |
Similar Items
-
Associating transcriptomics data with inflammatory markers to understand tumour microenvironment in hepatocellular carcinoma
by: Basak Bahcivanci, et al.
Published: (2023-01-01) -
Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
by: Yuanxin Shi, et al.
Published: (2023-05-01) -
An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma
by: Gen Li, et al.
Published: (2022-12-01) -
STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment
by: Zhangya Pu, et al.
Published: (2022-10-01) -
Identification of a CD4+ conventional T cells-related lncRNAs signature associated with hepatocellular carcinoma prognosis, therapy, and tumor microenvironment
by: Lin Zhu, et al.
Published: (2023-01-01)